Sie sind auf Seite 1von 6

Sharing the same challenges

from diagnosis,
the seeds of better health
Your daily guide

bioMérieux is committed to delivering


relevant microbiology solutions that
empower clinical decisions™.
VITEK® 2 technology
is like a lighthouse — This commitment has been our pride for over 40 years. Our efforts are
dedicated to developing innovative products in the field of microbial
a strong and universal
identification and susceptibility testing. Our solutions match your
symbol of trust, expectations as medical knowledge and technology continuously move
knowledge and forward. Our goal is the same as yours: finding new and better ways to
far-range vision. improve overall patient care.
Identifying bacterial resistance to enhance clinical guidance
Accurate microbial identification is the first step in achieving this goal.
bioMérieux is strongly anchored in this field with more than 40 years of
gold standard identification and susceptibility testing know-how.

bioMérieux is a pioneer in the development of Expert Systems.


Capability to detect resistance mechanisms is crucial to avoid
therapeutic failure. The VITEK 2 Advanced Expert™ System provides
accurate “fingerprint” recognition of bacterial resistance mechanisms
and phenotypes.
Faster results for relevant antibiotic therapy
Same-day results through rapid identification and antibiotic susceptibility
testing are made possible by automation and contribute to improved
patient outcomes.1, 2 The most important task facing the microbiology
laboratory is reporting rapid, accurate and clinically relevant results.

1. Barenfanger J, et al., “Clinical and Financial Benefits of Rapid Bacterial Identification and Antimicrobial Susceptibility Testing.” J Clin Micro, May 1999, 1415-18.
2. Thomas J, et al., “Outcomes Assessment Measuring Clinical and Financial Impact of Microbiologic Based Protocols : C ) Comparing Antimicrobial Susceptibility Reporting.” ASM 2000, Paper C-358.
Microbiology faces a broad
spectrum of challenges...
Anti-infective treatments represent a significant burden for • Increased healthcare costs
• Antibiotic misuse
hospital healthcare budgets. Microbiology laboratories play
• Hospital-acquired infections
a key role in helping to control the proper use of antibiotics.
• Increasing microbial resistances
Rapid and accurate reporting of antibiotic susceptibility test
results guides relevant therapeutic decisions. Targeted antibiotic
therapy depends on rapid, reliable microbiology results.

The microbiology laboratory has assumed a more prominent role in the


fight against hospital-acquired infections. Through resistance mechanism
detection, microbiologists are at the forefront of the fight against bacterial
resistance, a concern for any healthcare institution.

The increase in bacterial resistance is challenging our most effective


antibiotics. Identifying bacterial resistance as early as possible allows for
implementation of proactive measures and therapeutic adjustments. This
helps to prevent treatment failures and reduces emerging resistance.

In this challenging environment, microbiology must respond quickly and


implement new technology and processes to provide the best patient care
in the most efficient way.

…that impact
your daily activities.
• Report relevant results rapidly
• Be confident in the test results reported
• Ensure lab efficiency
• Be the expert in microbiology
Ready-to-go
in a sm
The new automated ID/AST system to access
VITEK® 2 technology and meet your daily challenges!

3 Steps to Set Up
• High level of automation
• Minimum hands-on and training time
• Pre-barcoded test cards ensure secure information
traceability from specimen to result

1 2 3

Minimal hands-on Traceability Load and go


VITEK 2 Compact
connects to STELLARA™

o technology • Allows real-time connectivity,


bringing laboratory results directly

mart design to clinicians via a wireless PDA

• Enables clinicians to optimize


therapy for better patient care

• Visit www.biomerieux-usa.com/stellara
for a demonstration
Powered by TheraDoc®

2 instrument sizes
adapted to your
laboratory:
• VITEK 2 Compact 30
• VITEK 2 Compact 60
A compact design for optimal space savings:
Height: 24" (60 cm) / Width: 28" (72 cm)
Depth: 27" (68 cm) / Weight: 165 lbs (75kg)

2 Clicks to Access Your Daily Work 1 Screen to Get Expert Advice


• Intuitive, icon-driven software • Easy graphical representation shows phenotype match,
• Routine tasks are one to two clicks away like a fingerprint
• Familiar Windows® format • One click for result validation
EMPOWER CLINICAL DECISIONS ARE TRADEMARKS OF BIOMÉRIEUX, THERADOC IS A REGISTERED TRADEMARK OF THERADOC, INC. AND WINDOWS IS A REGISTERED TRADEMARK OF MICROSOFT CORPORATION• PRINTED IN U.S.A. • VTK-157-05

Report it rapidly!
©2005 BIOMÉRIEUX, INC. • VITEK IS A REGISTERED TRADEMARK, AND THE LOGO IS A REGISTERED AND PROTECTED TRADEMARK OF BIOMÉRIEUX SA OR ONE OF ITS SUBSIDIARIES, ADVANCED COLORIMETRY, ADVANCED EXPERT AND

VITEK® 2 Card
A unique concept for same-day results
The VITEK® 2 card enhances:
Keep it relevant!
Laboratory efficiency Advanced Expert™ System
• Highest level of automation A unique interpretation
• No reagent addition software to ensure confidence in results
• Closed disposable for optimal user safety Antibiotic Susceptibility Test results coupled with
• Pre-applied card barcodes for maximum Advanced Expert™ System: an optimal level of
traceability information for the best clinical decision
• On average, there are five to seven MIC
Same-day result doubling dilutions per antibiotic
• Test card is read kinetically every 15
• Extended MIC range enables low-level
minutes for optimum time to result
resistance detection
• Mean time to ID/AST result is six to
• Resistance-oriented results which highlight
eight hours
unusual phenotypes
• Deduced antibiotic results to meet
formulary requirements
Get it right! • Every result is checked every time
Advanced Colorimetry™
A unique identification technology
to enhance performance
Over 98% of routine clinical isolates identified
with a single system
• New colorimetric substrates developed UNPARALLELED POWER
• > 100,000 reference database
• Highest discrimination between species • > 2,000 referenced phenotypes
• Lowest rate of multiple choice and • > 20,000 MIC distributions
mis-identified species • > 100 resistance mechanisms detected
• Low rate of off-line tests

bioMérieux, Inc. bioMérieux Canada, Inc.


100 Rodolphe Street 7815 Henri-Bourassa Boulevard West
Durham, NC 27712 St. Laurent (Québec) H4S 1P7
U.S.A. Canada
Tel: (800) 682 2666 Tel: (1) 514 336 7321
Fax: (800) 968 9494 Fax: (1) 514 807 0015

www.biomerieux-usa.com